Francois Nader

CIK: 0001365343

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (16.7%)

Derivative conversions

Awards (A)5 (83.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

MRNA

Moderna, Inc.

Director

TECX

Tectonic Therapeutic, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

MRNA
Moderna, Inc.
May 6, 2026
Award(A)
Stock Option (Right to Buy)
Direct
6.5K shares-
MRNA
Moderna, Inc.
May 6, 2026
Award(A)
Restricted Stock Units
Direct
4.2K shares-
MRNA
Moderna, Inc.
Apr 30, 2026
Exercise(M)
Direct
12.2K shares-
TECX
Tectonic Therapeutic, Inc.
Apr 1, 2026
Award(A)
Stock Option (Right to Buy)
Direct
20.4K shares-
MRNA
Moderna, Inc.
Apr 30, 2025
Award(A)
Stock Option (Right to Buy)
Direct
6.4K shares-
MRNA
Moderna, Inc.
Apr 30, 2025
Award(A)
Restricted Stock Units
Direct
12.2K shares-

		Type	Shares	Price		Ownership
May 6, 2026	MRNA Moderna, Inc.	Award(A) Stock Option (Right to Buy)	6,454	-	-	Direct
May 6, 2026	MRNA Moderna, Inc.	Award(A) Restricted Stock Units	4,185	-	-	Direct
Apr 30, 2026	MRNA Moderna, Inc.	Exercise(M)	12,174	-	$0	Direct
Apr 1, 2026	TECX Tectonic Therapeutic, Inc.	Award(A) Stock Option (Right to Buy)	20,400	-	-	Direct
Apr 30, 2025	MRNA Moderna, Inc.	Award(A) Stock Option (Right to Buy)	6,378	-	-	Direct
Apr 30, 2025	MRNA Moderna, Inc.	Award(A) Restricted Stock Units	12,174	-	-	Direct

1-6 of 6 transactions

About Nader Francois

Nader Francois (SEC CIK 0001365343) files insider reports with the SEC as Director of Moderna, Inc. (MRNA) and Director of Tectonic Therapeutic, Inc. (TECX).

Signal8 holds 5 ownership filings by Nader Francois (1 Form 3, 4 Form 4), filed between May 1, 2025 and May 8, 2026. Those filings report 6 transactions, from Apr 30, 2025 to May 6, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Nader Francois's filings is in WATERTOWN, MA.

Recent filings by Nader Francois

May 6, 2026: Grants or awards of MRNA derivative securities (2 lines, Form 4, code A).
Apr 30, 2026: Option exercise of MRNA shares (Form 4, code M).
Apr 1, 2026: Grant or award of TECX derivative securities (Form 4, code A).
Apr 30, 2025: Grants or awards of MRNA derivative securities (2 lines, Form 4, code A).

Other insiders filing for Moderna, Inc. (MRNA)

Hoge Stephen, President
Mock James M, Chief Financial Officer
Andres Juan, Chief Operating Officer
Klinger Shannon Thyme, Chief Legal Officer
Bancel Stephane, Chief Executive Officer
McDonnell Michael R., Director

How to read Form 4 transaction codes